+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Premature ovarian failure: predictability of intermittent ovarian function and response to ovulation induction agents

Premature ovarian failure: predictability of intermittent ovarian function and response to ovulation induction agents

Current Opinion in Obstetrics and Gynecology 20(4): 416-420

To summarize our current knowledge about the predictability of intermittent ovarian function and the response to ovulation induction agents in patients with premature ovarian failure. In addition to clinical, histological or ultrasonographic features, a new biological marker anti-Müllerian hormone, was evaluated as a marker for ovarian reserve in premature ovarian failure patients with encouraging results. Moreover, even if no treatment has proven to be effective enough to restore ovarian function, a recent study has presented a therapeutic protocol leading to a significant increase in ovulation and a higher pregnancy rate. Intermittent ovarian function can be spontaneously observed in premature ovarian failure patients. Clinical, biological and ovarian ultrasonographic features may allow an assessment of the presence of ovarian activity, but are not necessarily correlated with a higher ovulation or pregnancy rate. Nevertheless, it appears essential to characterize these patients to determine whether some of them could be candidates who benefit from a particular therapeutic strategy, although most such strategies have not yet demonstrated their efficiency.

(PDF emailed within 0-6 h: $19.90)

Accession: 055124547

Download citation: RISBibTeXText

PMID: 18660695

DOI: 10.1097/GCO.0b013e328306a06b

Related references

Ovulation induction by glucocorticoids in premature ovarian failure. Clinical & Investigative Medicine 15(4 SUPPL): A36, 1992

Ovulation induction in a woman with premature ovarian failure using buserelin and metrodin. Journal of Obstetrics & Gynaecology 11(2): 153, 1991

The effect of gonadotropin suppression on the induction of ovulation in premature ovarian failure patients. Fertility and Sterility 52(1): 36-41, 1989

The Effect of Gonadotropin Suppression on the Induction of Ovulation in Premature Ovarian Failure Patients. Obstetric and Gynecologic Survey 45(1): 61-63, 1990

Premature ovarian failure--the prognostic application of autoimmunity on conception after ovulation induction. Fertility and Sterility 59(4): 750-755, 1993

Ovulation induction in women with premature ovarian failure: a prospective, crossover study. Fertility and Sterility 57(2): 448-449, 1992

Natural history of ovarian function including assessment of ovarian reserve and premature ovarian failure. Best Practice and Research. Clinical Obstetrics and Gynaecology 2018, 2018

Ovulation induction with clomiphene citrate in a women with premature ovarian failure. A case report. Journal of Reproductive Medicine 33(6): 559-562, 1988

Ovulation induction in premature ovarian failure pof patients after estrogen induced gonadotropin suppression. The American Fertility Society Scientific Papers to Be Presented at The 43rd Annual Meeting Of The American Fertility Society, Reno, Nevada, Usa, September 28-30, Xxii+134p The American Fertility Society: Birmingham, Alabama, Usa Paper : 3, 1987

Induction of ovulation in idiopathic premature ovarian failure: a randomized double-blind trial. Reproductive Biomedicine Online 15(2): 215-219, 2007

Ovulation induction in a woman with premature ovarian failure resulting from a partial deletion of the X chromosome long arm, 46,X,del(X)(q22). Fertility and Sterility 68(5): 931-934, 1997

Spontaneous pregnancies despite failed attempts at ovulation induction in a woman with latrogenic premature ovarian failure. Journal of Reproductive Medicine 41(3): 207-210, 1996

Long-term outcome of ovarian function in women with intermittent premature ovarian insufficiency. Clinical Endocrinology 86(2): 223-228, 2016

A combination of gonadotropin-releasing hormone analog and human menopausal gonadotropins for ovulation induction in premature ovarian failure. Acta Obstetricia et Gynecologica Scandinavica 68(6): 571-573, 1989

Ovulation induction in premature ovarian failure: a placebo-controlled randomized trial combining pituitary suppression with gonadotropin stimulation. Fertility and Sterility 64(2): 273-278, 1995